Phibro Animal Health (PAHC) EPS Estimated At $0.39; Sio Capital Management Upped Medtronic Plc (MDT) Holding

January 14, 2018 - By Marguerite Chambers

Analysts expect Phibro Animal Health Corporation (NASDAQ:PAHC) to report $0.39 EPS on February, 5.They anticipate $0.00 EPS change or 0.00% from last quarter’s $0.39 EPS. PAHC’s profit would be $15.68 million giving it 22.88 P/E if the $0.39 EPS is correct. After having $0.38 EPS previously, Phibro Animal Health Corporation’s analysts see 2.63% EPS growth. The stock decreased 0.42% or $0.15 during the last trading session, reaching $35.7. About 43,051 shares traded. Phibro Animal Health Corporation (NASDAQ:PAHC) has risen 89.87% since January 14, 2017 and is uptrending. It has outperformed by 73.17% the S&P500.

Sio Capital Management Llc increased Medtronic Plc (MDT) stake by 86.15% reported in 2017Q3 SEC filing. Sio Capital Management Llc acquired 25,844 shares as Medtronic Plc (MDT)’s stock rose 5.51%. The Sio Capital Management Llc holds 55,844 shares with $4.34M value, up from 30,000 last quarter. Medtronic Plc now has $115.66B valuation. The stock decreased 0.33% or $0.28 during the last trading session, reaching $85.45. About 5.09M shares traded. Medtronic plc (NYSE:MDT) has risen 4.04% since January 14, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

Investors sentiment decreased to 1.48 in 2017 Q3. Its down 0.44, from 1.92 in 2017Q2. It fall, as 10 investors sold Phibro Animal Health Corporation shares while 46 reduced holdings. 25 funds opened positions while 58 raised stakes. 19.38 million shares or 1.59% more from 19.08 million shares in 2017Q2 were reported. National Bank Of Mellon has 0% invested in Phibro Animal Health Corporation (NASDAQ:PAHC). The Michigan-based Ls Inv Advsrs Ltd Com has invested 0% in Phibro Animal Health Corporation (NASDAQ:PAHC). Prudential holds 141,760 shares. Paradigm Asset Mgmt Company Limited Liability Corporation reported 16,460 shares or 0.16% of all its holdings. Bogle Mgmt L P De has invested 0.22% in Phibro Animal Health Corporation (NASDAQ:PAHC). Hbk Investments Limited Partnership, a Texas-based fund reported 24,610 shares. 2.80 million were accumulated by Blackrock. Prelude Capital Mngmt Ltd holds 0.03% or 8,100 shares. 4,878 are held by Mason Street Advsrs Limited Liability Corporation. Thornburg Investment Mngmt has invested 0.11% in Phibro Animal Health Corporation (NASDAQ:PAHC). Barclays Public Ltd Liability Co reported 6,761 shares. Hillsdale Management owns 35,500 shares. S Muoio And Co Ltd Liability Corp accumulated 32,790 shares. Fuller & Thaler Asset Incorporated holds 177,250 shares or 0.08% of its portfolio. Laurion Cap Mgmt L P holds 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC) for 9,464 shares.

Since August 14, 2017, it had 0 insider purchases, and 10 insider sales for $9.47 million activity. 4,976 shares valued at $199,098 were sold by Bendheim Daniel M on Thursday, August 17. Another trade for 29,807 shares valued at $1.06 million was sold by Johnson Richard G. Carlson Gerald K sold $195,858 worth of stock. 10,000 shares were sold by Warras Dean J, worth $357,008. Miller Larry Lee also sold $1.67 million worth of Phibro Animal Health Corporation (NASDAQ:PAHC) shares.

Among 8 analysts covering Philbro Animal Health (NASDAQ:PAHC), 4 have Buy rating, 3 Sell and 1 Hold. Therefore 50% are positive. Philbro Animal Health had 16 analyst reports since September 30, 2015 according to SRatingsIntel. The firm has “Underweight” rating given on Monday, January 18 by Barclays Capital. Barclays Capital downgraded it to “Underweight” rating and $31 target in Friday, January 15 report. The company was initiated on Wednesday, September 30 by Gabelli. The rating was maintained by Credit Suisse on Thursday, August 31 with “Outperform”. On Thursday, August 31 the stock rating was maintained by Piper Jaffray with “Buy”. The rating was maintained by Piper Jaffray with “Buy” on Friday, October 6. Bank of America maintained it with “Underperform” rating and $33 target in Wednesday, August 23 report. Piper Jaffray maintained the shares of PAHC in report on Friday, August 25 with “Buy” rating. Macquarie Research downgraded the stock to “Underperform” rating in Friday, November 11 report. The stock of Phibro Animal Health Corporation (NASDAQ:PAHC) has “Hold” rating given on Thursday, November 10 by Gabelli.

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition firm primarily in the United States. The company has market cap of $1.44 billion. It operates through three divisions: Animal Health, Mineral Nutrition, and Performance Products. It has a 21.14 P/E ratio. The firm develops, makes, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Investors sentiment increased to 1.12 in 2017 Q3. Its up 0.22, from 0.9 in 2017Q2. It increased, as 73 investors sold MDT shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. Haverford Trust reported 1.06 million shares stake. Hanson Mcclain Inc reported 7,196 shares or 0.05% of all its holdings. Mufg Americas Corp invested in 0.49% or 196,875 shares. Aqr Cap Mgmt Lc holds 528,182 shares or 0.05% of its portfolio. Atria Ltd Llc, North Carolina-based fund reported 10,549 shares. Warren Averett Asset Mngmt Ltd Com holds 0.19% of its portfolio in Medtronic plc (NYSE:MDT) for 11,178 shares. Public Sector Pension Board owns 266,326 shares or 0.09% of their US portfolio. 34,100 were reported by Friess Assoc Ltd Limited Liability Company. Verition Fund Management Lc invested in 43,691 shares. Virtu Fin Limited Liability Corp has invested 0% in Medtronic plc (NYSE:MDT). Stevens First Principles Invest accumulated 2,771 shares. Qs Limited Liability Company invested in 0.05% or 74,665 shares. Ferguson Wellman Mgmt, a Oregon-based fund reported 12,523 shares. Lombard Odier Asset Mgmt (Europe) Ltd reported 15,834 shares. Cibc Asset Mgmt invested in 0.05% or 93,942 shares.

Among 28 analysts covering Medtronic (NYSE:MDT), 19 have Buy rating, 0 Sell and 9 Hold. Therefore 68% are positive. Medtronic had 78 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was maintained by SunTrust with “Buy” on Monday, June 13. Jefferies maintained Medtronic plc (NYSE:MDT) rating on Tuesday, June 27. Jefferies has “Buy” rating and $9700 target. The rating was upgraded by Argus Research to “Buy” on Tuesday, December 12. The rating was maintained by Oppenheimer with “Buy” on Monday, June 26. As per Friday, April 21, the company rating was maintained by Northland Capital. As per Tuesday, August 22, the company rating was maintained by BTIG Research. Deutsche Bank maintained Medtronic plc (NYSE:MDT) rating on Thursday, June 2. Deutsche Bank has “Buy” rating and $92 target. Northland Capital maintained the shares of MDT in report on Wednesday, August 23 with “Hold” rating. The firm has “Buy” rating given on Wednesday, August 23 by Jefferies. The stock of Medtronic plc (NYSE:MDT) has “Outperform” rating given on Wednesday, November 23 by BMO Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>